Par Pharmaceutical Receives Approval Of Generic Inderal-LA(R)

Tue, 30 Jan 2007 02:00 PM EST

... Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced it has received final approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for propranolol hydrochloride (HCl) extended release (ER) capsules in 60-, 80-, 120- and 160 mg dosage strengths. [click link for full article] ...